PE20160212A1 - Comprimido farmaceutico que comprende acido acetilsalicilico y clopidogrel - Google Patents
Comprimido farmaceutico que comprende acido acetilsalicilico y clopidogrelInfo
- Publication number
- PE20160212A1 PE20160212A1 PE2016000120A PE2016000120A PE20160212A1 PE 20160212 A1 PE20160212 A1 PE 20160212A1 PE 2016000120 A PE2016000120 A PE 2016000120A PE 2016000120 A PE2016000120 A PE 2016000120A PE 20160212 A1 PE20160212 A1 PE 20160212A1
- Authority
- PE
- Peru
- Prior art keywords
- clopidogrel
- pharmaceutical tablets
- tablets including
- core
- layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invencion se refiere a un comprimido que comprende un nucleo y una capa externa, comprendiendo el nucleo acido acetilsalicilico o una de sus sales farmaceuticamente aceptables y comprendiendo la capa externa clopidogrel o una de sus sales farmaceuticamente aceptables, estando separado el nucleo de la capa externa por un recubrimiento de tres capas compuesto de una capa gastrorresistente insertada entre dos capas aislantes
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/FR2013/051874 WO2015015062A1 (fr) | 2013-08-02 | 2013-08-02 | Comprime pharmaceutique comprenant de l'acide acetylsalicylique et du clopidogrel |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20160212A1 true PE20160212A1 (es) | 2016-05-09 |
Family
ID=49085055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2016000120A PE20160212A1 (es) | 2013-08-02 | 2014-07-25 | Comprimido farmaceutico que comprende acido acetilsalicilico y clopidogrel |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP3027176B1 (es) |
JP (1) | JP5905165B2 (es) |
KR (1) | KR102243349B1 (es) |
CN (1) | CN105407877B (es) |
AR (1) | AR097193A1 (es) |
BR (1) | BR112016001822B1 (es) |
CL (1) | CL2016000143A1 (es) |
CR (1) | CR20160067A (es) |
DO (1) | DOP2016000024A (es) |
ES (1) | ES2648913T3 (es) |
HK (1) | HK1221649A1 (es) |
MY (1) | MY176793A (es) |
PE (1) | PE20160212A1 (es) |
PH (1) | PH12016500121B1 (es) |
SG (1) | SG11201600218SA (es) |
TW (1) | TWI642435B (es) |
WO (2) | WO2015015062A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104800183B (zh) * | 2015-04-14 | 2016-08-31 | 陕西必康制药集团控股有限公司 | 一种阿司匹林肠溶片及其制备方法和应用 |
CN108289849A (zh) * | 2015-06-26 | 2018-07-17 | 韩国联合制药株式会社 | 莫沙必利与雷贝拉唑的复合制剂 |
WO2017037741A1 (en) * | 2015-09-02 | 2017-03-09 | Sun Pharmaceutical Industries Ltd | Compact solid dosage form of aspirin and clopidogrel |
CN107308157B (zh) * | 2017-06-08 | 2020-02-21 | 广州白云山天心制药股份有限公司 | 一种含有氯吡格雷的复方口服固体制剂及其制备方法 |
WO2019030610A1 (en) * | 2017-08-11 | 2019-02-14 | Solutions In Innovative Research Pvt. Ltd. | PHARMACEUTICAL COMPOSITIONS WITH DUAL DIRECTLY COMPRESSIBLE MEDICAMENT RELEASE |
CN107693524A (zh) * | 2017-10-23 | 2018-02-16 | 罗铭炽 | 一种含阿司匹林和氯吡格雷的制备方法 |
CN107669690A (zh) * | 2017-10-23 | 2018-02-09 | 罗铭炽 | 一种含阿司匹林和氯吡格雷的片剂 |
CN109528668A (zh) * | 2018-12-20 | 2019-03-29 | 华中药业股份有限公司 | 阿司匹林片及其制备方法 |
CN112587495A (zh) * | 2020-12-14 | 2021-04-02 | 乐普药业股份有限公司 | 一种阿司匹林和硫酸氢氯吡格雷复方制剂及其制备方法 |
EP4091605A1 (en) | 2021-05-19 | 2022-11-23 | G.L. Pharma GmbH | Pharmaceutical tablet comprising acetylsalicylic acid |
CN115212180B (zh) * | 2022-09-03 | 2024-05-10 | 深圳市信宜特科技有限公司 | 一种阿司匹林和硫酸氢氯吡格雷的复方制剂及其制备方法 |
KR20240050841A (ko) * | 2022-10-12 | 2024-04-19 | 일양약품주식회사 | 클로피도그렐 및 일라프라졸을 포함하는 복합제제 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04346930A (ja) * | 1991-05-25 | 1992-12-02 | Sumitomo Pharmaceut Co Ltd | 安定なアスピリン腸溶錠 |
FR2744918B1 (fr) | 1996-02-19 | 1998-05-07 | Sanofi Sa | Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique |
FR2779726B1 (fr) | 1998-06-15 | 2001-05-18 | Sanofi Sa | Forme polymorphe de l'hydrogenosulfate de clopidogrel |
FR2792836B3 (fr) * | 1999-04-30 | 2001-07-27 | Sanofi Sa | Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel |
CN101703513B (zh) * | 2009-11-10 | 2014-04-23 | 沈阳药科大学 | 阿司匹林和氯吡格雷或其药学上可接受的盐的复方缓释制剂 |
US20130059062A1 (en) * | 2010-03-11 | 2013-03-07 | Ramakant Kashinath Gundu | Device For The Manufacture Of A Dosage Form With A Hole And Method Of Manufacture |
CN101874786B (zh) * | 2010-06-05 | 2012-04-25 | 浙江金华康恩贝生物制药有限公司 | 无溶剂挤出滚圆法制备阿司匹林肠溶制剂 |
KR20120068277A (ko) * | 2010-12-17 | 2012-06-27 | 한미사이언스 주식회사 | HMG-CoA 환원효소 억제제 및 아스피린을 포함하는 약제학적 복합제제 |
US20150079169A1 (en) * | 2011-09-14 | 2015-03-19 | Pozen Inc. | Controlled dosing of clopidogrel with gastric acid inhibition therapies |
KR101675501B1 (ko) * | 2011-11-02 | 2016-11-14 | 한국유나이티드제약 주식회사 | 클로피도그렐 및 아스피린의 복합제제 |
WO2013133620A1 (en) * | 2012-03-09 | 2013-09-12 | Yuhan Corporation | Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same |
-
2013
- 2013-08-02 JP JP2015529093A patent/JP5905165B2/ja active Active
- 2013-08-02 WO PCT/FR2013/051874 patent/WO2015015062A1/fr active Application Filing
-
2014
- 2014-07-25 EP EP14753025.7A patent/EP3027176B1/en active Active
- 2014-07-25 WO PCT/EP2014/066110 patent/WO2015014766A1/en active Application Filing
- 2014-07-25 MY MYPI2016700042A patent/MY176793A/en unknown
- 2014-07-25 ES ES14753025.7T patent/ES2648913T3/es active Active
- 2014-07-25 CN CN201480042849.3A patent/CN105407877B/zh active Active
- 2014-07-25 BR BR112016001822-2A patent/BR112016001822B1/pt active IP Right Grant
- 2014-07-25 PE PE2016000120A patent/PE20160212A1/es unknown
- 2014-07-25 KR KR1020167004776A patent/KR102243349B1/ko active IP Right Grant
- 2014-07-25 SG SG11201600218SA patent/SG11201600218SA/en unknown
- 2014-08-01 TW TW103126491A patent/TWI642435B/zh active
- 2014-08-01 AR ARP140102898A patent/AR097193A1/es unknown
-
2016
- 2016-01-19 DO DO2016000024A patent/DOP2016000024A/es unknown
- 2016-01-19 PH PH12016500121A patent/PH12016500121B1/en unknown
- 2016-01-20 CL CL2016000143A patent/CL2016000143A1/es unknown
- 2016-02-09 CR CR20160067A patent/CR20160067A/es unknown
- 2016-08-17 HK HK16109836.1A patent/HK1221649A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP3027176A1 (en) | 2016-06-08 |
WO2015015062A1 (fr) | 2015-02-05 |
TW201601721A (zh) | 2016-01-16 |
AR097193A1 (es) | 2016-02-24 |
CR20160067A (es) | 2016-04-01 |
KR20160037967A (ko) | 2016-04-06 |
PH12016500121A1 (en) | 2016-04-25 |
EP3027176B1 (en) | 2017-08-23 |
SG11201600218SA (en) | 2016-02-26 |
MY176793A (en) | 2020-08-21 |
JP2015526498A (ja) | 2015-09-10 |
CL2016000143A1 (es) | 2016-06-24 |
ES2648913T3 (es) | 2018-01-08 |
HK1221649A1 (zh) | 2017-06-09 |
CN105407877A (zh) | 2016-03-16 |
CN105407877B (zh) | 2019-05-07 |
JP5905165B2 (ja) | 2016-04-20 |
BR112016001822B1 (pt) | 2022-10-18 |
KR102243349B1 (ko) | 2021-04-21 |
PH12016500121B1 (en) | 2016-04-25 |
TWI642435B (zh) | 2018-12-01 |
BR112016001822A2 (pt) | 2017-08-01 |
DOP2016000024A (es) | 2016-03-30 |
WO2015014766A1 (en) | 2015-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20160212A1 (es) | Comprimido farmaceutico que comprende acido acetilsalicilico y clopidogrel | |
CR20140486A (es) | Formulacion de farmaco de liberacion retardada | |
CO2017012362A2 (es) | Formas de dosificación sólida que comprenden palbociclib, un ácido hidrosoluble y un portador farmacéuticamente aceptable y métodos para su produccion y uso | |
NI201600058A (es) | Compuestos derivados de piridilo bicíclicos fusionados a anillo como inhibidores de fgfr4 | |
CR20160192A (es) | Formulación de farmaco de liberación retardada | |
AR085547A1 (es) | Composicion compleja oral que comprende ester del acido graso omega-3 y un inhibidor de la hmg-coa reductasa | |
CR20150647A (es) | Sistema de liberación transdérmica | |
DOP2015000183A (es) | Formulaciones farmacéuticas resistentes a la manipulación indebida | |
HK1222550A1 (zh) | 羥化酶抑制劑的藥物製劑 | |
CR20150077A (es) | Composición farmacéutica oral en forma de microesferas y proceso de elaboración | |
CR20130287A (es) | Tableta oralmente desintegradora | |
PH12014501218B1 (en) | Dry coated tablet | |
IN2015DN04161A (es) | ||
CL2013003585A1 (es) | Procedimiento para preparar una tableta de caldo que tiene dos o más capas, el cual consiste en las etapas de (a) formar una primera capa de la tableta, (b) formar una segunda capa de la tableta y (c) comprimir las dos capas para formar la tableta. | |
PT3060203T (pt) | Comprimido efervescente que contém um teor elevado de aspirina | |
BR112014019526B8 (pt) | Forma de dosagem de liberação rápida e seu método de produção | |
UY35000A (es) | ?formulación de una cápsula farmacéutica compuesta que comprende irbesartan e inhibidor de la hmg-coa reductasa?. | |
UY35690A (es) | Composiciones farmacéuticas de ranolazina y dronedarona | |
SV2013004396A (es) | Composición farmacéutica de liberación prolongada de trimetazidina | |
PH12015000297B1 (en) | Pharmaceutical combination preparation | |
FR2980178B1 (fr) | Etui de rangement et de transport de medicaments et procede de fabrication correspondant | |
TH1601000441A (th) | ยาเม็ดแบนทางเภสัชกรรมซึ่งประกอบรวมด้วยอะเซทิลซาลิคไซลิคแอซิดและ โคลพิโดเกรล | |
TH153153A (th) | ยาเม็ดเคลือบแห้ง | |
CL2016000529A1 (es) | Capa de recubrimiento aislante entre un núcleo que comprende al fármaco y un recubrimiento exterior compuesto por una capa interna y una capa externa, su uso, una formulación de fármaco que contiene a dicha capa aislante, un método para producir a la formulación. | |
WO2015043764A3 (en) | Protein phosphatase inhibitor |